Cargando…

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

BACKGROUND: The incidence of nasopharyngeal carcinoma (NPC) is rare, but a certain amount of mortality remains in NPC patients. Our study aimed to identify candidate genes as biomarkers for NPC screening, diagnosis, and therapy. METHODS: We investigated two microarray profile datasets GSE64634 and G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Zhimin, Wang, Fangzheng, Yan, Fengqin, Wang, Lei, Li, Bin, Liu, Tongxin, Hu, Fujun, Jiang, Mingxiang, Li, Weiyang, Fu, Zhenfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444505/ https://www.ncbi.nlm.nih.gov/pubmed/30935420 http://dx.doi.org/10.1186/s12957-019-1605-9

Ejemplares similares

Clinical and imaging characteristics of 53 ulcers of post-radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
por: Yan, Fengqin, et al.
Publicado: (2016)

Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution
por: Fangzheng, Wang, et al.
Publicado: (2018)

Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2020)

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2020)

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience
por: Wang, Fangzheng, et al.
Publicado: (2017)

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis
por: Fangzheng, Wang, et al.
Publicado: (2017)

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study
por: Liu, Tongxin, et al.
Publicado: (2018)

Bioinformatics-based analysis of the lncRNA–miRNA–mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma
por: Ye, Zhimin, et al.
Publicado: (2020)

The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Yongfeng, Piao, et al.
Publicado: (2021)

A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Liu, Tongxin, et al.
Publicado: (2018)

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Therapeutic patterns and outcomes in older patients (aged ≥65 years) with stage II-IVB Nasopharyngeal Carcinoma: an investigational study from SEER database
por: Piao, Yongfeng, et al.
Publicado: (2020)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2017)

Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma: A SEER population-based study
por: Lu, Yan, et al.
Publicado: (2021)

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients
por: Fangzheng, Wang, et al.
Publicado: (2018)

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: Single-center experience from an endemic area
por: Fangzheng, Wang, et al.
Publicado: (2019)

miR-195 is a key regulator of Raf1 in thyroid cancer
por: Wang, Fangzheng, et al.
Publicado: (2015)

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2018)

Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2016)

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2018)

A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway
por: Fang, Jun, et al.
Publicado: (2020)

Methodology of dose calculation for external beam radiation combined with high dose rate brachytherapy in the era of 3-dimensional treatment planning system
por: Wang, Fangzheng, et al.
Publicado: (2020)

ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients
por: Chen, Ying, et al.
Publicado: (2019)

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis
por: Wen, Pushuai, et al.
Publicado: (2018)

Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning
por: Liang, Yihao, et al.
Publicado: (2022)

Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis
por: Luo, Yongqi, et al.
Publicado: (2020)

Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors
por: Ye, Zhimin, et al.
Publicado: (2017)

Clinical and prognostic analyses of 110 patients with N(3) nasopharyngeal carcinoma
por: Chen, Jing, et al.
Publicado: (2018)

The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis
por: Lu, Youwei, et al.
Publicado: (2021)

Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis
por: Zhang, Ji-Zhou, et al.
Publicado: (2019)

Identification of Candidate Biomarkers for Salt Sensitivity of Blood Pressure by Integrated Bioinformatics Analysis
por: Chen, Chen, et al.
Publicado: (2020)

Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis
por: Chen, Fang, et al.
Publicado: (2017)

Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis
por: Kolur, Vijayakrishna, et al.
Publicado: (2021)

Genome-wide identification and bioinformatics analysis of the WRKY transcription factors and screening of candidate genes for anthocyanin biosynthesis in azalea (Rhododendron simsii)
por: Wang, Cheng, et al.
Publicado: (2023)

Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation
por: Liu, Shuai, et al.
Publicado: (2021)

Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection
por: Luo, Kang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5sc9917690tor1duig8fgvqh2p